NVO Operating Cash Flow Growth
Novo Nordisk A/S Common Stock · Operating Cash Flow Growth
NVO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported9.45%period ending
NVO TTM Cash from Operations YoY % (13.80% → 9.45%)
Year-over-year change
High-resolution chart · PNG
NVO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 9.4481% | |
| -9.6385% | |
| -1.5426% | |
| 4.7083% | |
| 5.3696% | |
| 40.5072% | |
| 11.0736% | |
| 11.0466% | |
| 28.5331% | |
| 9.7433% | |
| 38.0557% | |
| 54.8052% | |
| 35.8799% | |
| 26.4128% | |
| 43.4309% | |
| 18.1821% | |
| 21.8665% | |
| 26.5763% | |
| 5.869% | |
| 2.1864% | |
| -3.4529% | |
| 13.4104% | |
| 11.0491% | |
| 16.1435% | |
| 27.6752% | |
| 4.9518% | |
| 4.8548% | |
| 13.3986% | |
| -1.2978% | |
| 14.9312% | |
| 8.3754% | |
| -6.5955% | |
| -8.2769% | |
| -26.5448% | |
| -14.7907% | |
| -2.096% | |
| 9.9097% | |
| 27.0813% | |
| 26.189% | |
| 33.2995% | |
| 24.1751% | |
| 31.2868% | |
| 20.8097% | |
| 19.1715% | |
| 49.5942% | |
| 38.307% | |
| 22.1648% | |
| 34.7718% | |
| -0.193% | |
| 2.5571% | |
| 16.7822% | |
| -10.5223% | |
| -2.6315% | |
| -3.5029% | |
| 3.93% | |
| 10.6871% | |
| 17.309% | |
| 12.77% | |
| 8.6132% | |
| 21.4686% | |
| 22.1572% | |
| 32.9539% | |
| 27.9685% | |
| 22.0667% | |
| 24.9996% | |
| 10.6255% | |
| 19.2378% | |
| 23.6049% | |
| 13.9038% | |
| 32.8982% | |
| 28.9967% | |
| 55.105% | |
| 52.2891% | |
| 28.2673% | |
| 29.1494% | |
| -19.429% | |
| -13.6165% | |
| -13.2199% | |
| -11.0141% | |
| 15.2318% | |
| 13.6045% | |
| 23.5307% | |
| 13.8004% |